Fusion Closes on Approximately $44.0 Million of Financing

New Post Public Reply Private Reply Replies (0) Message Board
iggyman555
Fusion Closes on Approximately $44.0 Million of Financing

Jan 06, 2014 10:45:00 (ET)

Fusion Closes on Approximately $44.0 Million of Financing

Enables Acquisition of Cloud Services Business

NEW YORK, NY--(Marketwired - Jan 6, 2014) - Fusion (OTCQB: FSNN), an emerging leader in the cloud services market, today announced that on December 31, 2013, it closed several financing transactions aggregating to approximately $44.0 million, comprised of approximately $18.5 million in equity, and $25.5 million in term debt.

Fusion raised approximately $18.5 million through a private placement of investment units consisting of Convertible Preferred Securities and Warrants to accredited investors, including all members of Fusion's Board of Directors and members of its Advisory Board. As part of the capital raised in the offering, Matthew Rosen, Fusion's Chief Executive Officer and Marvin Rosen, Fusion's Chairman, exchanged $2.05 million of Company obligations for the investment units sold in the private placement. Fusion received net cash proceeds in the private placement, after giving effect to transaction expenses, of approximately $15.6 million.

Aegis Capital Corp. served as lead placement agent.

In addition to the equity, Fusion raised $25.5 million through the issuance of 5-year senior notes to Praesidian Capital and Plexus Capital, Fusion's existing lenders.

The Company's aggregate net proceeds from these financing transactions was $40.5 million, $32.1 million of which was used to fund its acquisition of the cloud services assets of Broadvox's business services division, with the remainder to be used for acquisition transaction expenses, to advance sales and marketing efforts, and for general corporate purposes. The Broadvox cloud services unit will be integrated into NBS, Fusion's cloud services division. NBS was acquired in October, 2012, and fully integrated by the end of the first quarter of 2013. The addition of NBS' proprietary platform and infrastructure has accelerated Fusion's organic growth and enabled the Company to effectively integrate the current acquisition of Broadvox's cloud services, as well as facilitate future accretive acquisitions.

"The strong support we received in the financing from new and existing shareholders, Directors, Advisory Board members, and from financial partners such as Praesidian Capital, Plexus Capital, and several other notable institutions and individuals, reaffirms our confidence that we have the right strategy for growth," said Matthew Rosen, Fusion's Chief Executive Officer. "This financing advances our cloud services strategy with an acquisition that will allow us to rapidly scale, accelerate our organic growth and effectively plan for additional strategic acquisitions as we emerge as a leading provider in the cloud services marketplace," continued Mr. Rosen.

Commenting on the transaction, Glenn C. Harrison, Managing Director of Praesidian, said, "Since our initial investment, we have become very familiar with the talented Fusion management team through this acquisition as well as their acquisition of NBS last year, and have found them to be both innovative and experienced. Their success at meeting key goals in 2013 confirms our confidence in what we believe to be a winning strategy and plan."

Expanding on Mr. Harrison's comments, Mike Becker, co-founder and Partner of Plexus, said, "We believe this financing strongly reflects our commitment to support Fusion in the execution of its strategy."

Further details of the equity financing are contained in Fusion's Current Report on Form 8-K filed today with the SEC.

Fusion Connect, Inc. (FSNNQ) Stock Research Links

FSNNQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 136

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 80

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 53

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 208

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 206

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 68

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 153

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 17

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 277

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 287

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Elections: How EP3 Technology Transformed Voting

Updated Category News Views 114

EP3 Technology Powers Transformative Election Insights ForecastEx, a dynamic subsidiary of Interactive Brokers (IBKR), achieved a remarkable feat by processing over $560 million in election contracts during the 2024 U.S. general election. The groundbreaking technology enabling this achievement is Connamara Technologies' EP3 matching engine, an innovative platform designed...

Continue Reading
GI Partners and Legacy Investing Transform Chicago Landmark

Updated Category News Views 269

Transforming a Chicago Landmark into a Modern Data Center The historic 300,500 square foot building located at 400 S. LaSalle Street, once the home of the Chicago Board Options Exchange, is set to undergo an exciting transformation. Through an acquisition announced recently, GI Partners and Legacy Investing, LLC have acquired this prominent property with the intention of...

Continue Reading
Radiotherapy Market to Hit $10.68B in 2031, Growth Ahead

Updated Category News Views 30

Radiotherapy Market's Projected Growth: What's Fueling It? It's no secret: the radiotherapy market is on an upward trajectory, heading toward a substantial $10.68 billion valuation by 2031. But what’s pushing this rocket? For starters, we’re looking at a steady compound annual growth rate (CAGR) of 6.0% from 2026 to 2031. Not too shabby in today’s volatile economic...

Continue Reading
Join the Class Action Against Newmont Corporation by April 2025

Updated Category News Views 254

Take Action: Class Action Against Newmont Corporation Levi & Korsinsky, LLP is reaching out to investors linked to Newmont Corporation, urging them to act before the April 1, 2025 deadline for joining a class action lawsuit. This lawsuit addresses alleged securities fraud that negatively impacted many of Newmont's investors. Understanding the Class Action The class action...

Continue Reading
InflaRx Unveils Promising Preclinical Findings for INF904

Updated Category News Views 76

InflaRx Unveils New Developments for INF904 InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company recognized for its innovative anti-inflammatory therapies targeting the complement system, has recently shared promising preclinical results for its oral C5aR inhibitor, INF904. This announcement took place at the 2024 European Meeting on Complement in Human Diseases...

Continue Reading